Home/Filings/4/0001209191-22-047540
4//SEC Filing

Hillan Kenneth J. 4

Accession 0001209191-22-047540

CIK 0001804591other

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 5:00 PM ET

Size

5.0 KB

Accession

0001209191-22-047540

Insider Transaction Report

Form 4
Period: 2022-08-24
Hillan Kenneth
Head of Therapeutics
Transactions
  • Sale

    Class A Common Stock

    2022-08-24$3.64/sh8,753$31,861196,083 total

Issuer

23andMe Holding Co.

CIK 0001804591

Entity typeother

Related Parties

1
  • filerCIK 0001600359

Filing Metadata

Form type
4
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 5:00 PM ET
Size
5.0 KB